Loss of heterozygosity and promoter methylation, but not mutation, may underlie loss of TFF1 in gastric carcinoma

Laboratory Investigation

Volumn 82, Issue 10, 2002, Pages 1319-1326

  Carvalho, Ralph ^a   Kayademir, Tuncay ^c   Soares, Paula ^a,b   Canedo, Paulo ^a,b   Sousa, Sónia ^a   Oliveira, Carla ^a   Leistenschneider, Peter ^c   Seruca, Raquel ^a,b   Gött, Peter ^c   Blin, Nikolaus ^c   Carneiro, Fátima ^a,b   Machado, José Carlos ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b HOSPITAL DE SÃO JOÃO   (Portugal)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; TREFOIL PEPTIDE;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DNA METHYLATION; GENE EXPRESSION; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; TUMOR SUPPRESSOR GENE;

DNA METHYLATION; GENE DELETION; GROWTH SUBSTANCES; HUMANS; LOSS OF HETEROZYGOSITY; MUTATION; PEPTIDES; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); PROTEINS; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0036800412     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.LAB.0000029205.76632.A8     Document Type: Article

References (23)

1. Al azzeh ED, Fegert P, Blin N, and Gott P (2000). Transcription factor GATA-6 activates expression of gastroprotective trefoil genes TFF1 and TFF2. Biochim Biophys Acta 1490:324-332.
2. Beck S, Sommer P, dos Santos Silva E, Blin N, and Gott P (1999). Hepatocyte nuclear factor 3 (winged helix domain) activates trefoil factor gene TFF1 through a binding motif adjacent to the TATAA box. DNA Cell Biol 18:157-164.
3. Berry A, Scott HS, Kudoh J, Talior I, Korostishevsky M, Wattenhofer M, Guipponi M, Barras C, Rossier C, Shibuya K, Wang J, Kawasaki K, Asakawa S, Minoshima S, Shimizu N, Antonarakis S, and Bonne-Tamir B (2000). Refined localization of autosomal recessive nonsyndromic deafness DFNB10 locus using 34 novel microsatellite markers, genomic structure, and exclusion of six known genes in the region. Genomics 68:22-29.
4. Carvalho B, van der Veen A, Gartner F, Carneiro F, Seruca R, Buys CH, and Kok K (2001). Allelic gains and losses in distinct regions of chromosome 6 in gastric carcinoma. Cancer Genet Cytogenet 131:54-59.
5. Chomczynski P and Sacchi N (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal Biochem 162:156-159.
6. Fujimoto J, Yasui W, Tahara H, Tahara E, Kudo Y, and Yokozaki H (2000). DNA hypermethylation at the pS2 promoter region is associated with early stage of stomach carcinogenesis. Cancer Lett 149:125-134.
7. Gärtner F, David L, Seruca R, Machado JC, and Sobrinho-Simões M (1996). Establishment and characterization of two cell lines derived from human diffuse gastric carcinomas xenografted in nude mice. Virchows Arch 428:91-98.
8. Herman JG, Graff JR, Myohanen S, Nelkin BD, and Baylin SB (1996). Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93:9821-9826.
9. Lefebvre O, Chenard MP, Masson R, Linares J, Dierich A, LeMeur M, Wendling C, Tomasetto C, Chambon P, and Rio MC (1996). Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science 274:259-262.
10. Machado JC, Carneiro F, Blin N, and Sobrinho-Simões M (1996a). Pattern of pS2 protein expression in premalignant and malignant lesions of gastric mucosa. Eur J Cancer Prev 5:169-179.
11. Machado JC, Carneiro F, Ribeiro P, Blin N, and Sobrinho-Simões M (1996b). pS2 protein expression in gastric carcinoma. An immunohistochemical and immunoradiometric study. Eur J Cancer 32A:1585-1590.
12. Martin V, Ribieras S, Song-Wang X, Rio MC, and Dante R (1995). Genomic sequencing indicates a correlation between DNA hypomethylation in the 5′ region of the pS2 gene and its expression in human breast cancer cell lines. Gene 157:261-264.
13. Martin V, Ribieras S, Song-Wang XG, Lasne Y, Frappart L, Rio MC, and Dante R (1997). Involvement of DNA methylation in the control of the expression of an estrogen-induced breast-cancer-associated protein (pS2) in human breast cancers. J Cell Biochem 65:95-106.
14. Motoyama T, Hojo H, and Watanabe H (1986). Comparison of seven cell lines derived from human gastric carcinomas. Acta Pathol Jpn 36:65-83.
15. Park WS, Oh RR, Park JY, Lee JH, Shin MS, Kim HS, Lee HK, Kim YS, Kim SY, Lee SH, Yoo NJ, and Lee JY (2000). Somatic mutations of the trefoil factor family 1 gene in gastric cancer. Gastroenterology 119:691-698.
16. Rio MC, Bellocq JP, Daniel JY, Tomasetto C, Lathe R, Chenard MP, Batzenschlager A, and Chambon P (1988). Breast cancer-associated pS2 protein: Synthesis and secretion by normal stomach mucosa. Science 241:705-708.
17. Sakata K, Tamura G, Nishizuka S, Maesawa C, Suzuki Y, Iwaya T, Terashima M, Saito K, and Satodate R (1997). Commonly deleted regions on the long arm of chromosome 21 in differentiated adenocarcinoma of the stomach. Genes Chromosom Cancer 18:318-321.
18. Sekiguchi M, Sakakibara K, and Fujii G (1978). Establishment of cultured cell lines derived from a human gastric carcinoma. Jpn J Exp Med 48:61-68.
19. Sommer P, Blin N, and Gott P (1999). Tracing the evolutionary origin of the TFF-domain, an ancient motif at mucous surfaces. Gene 236:133-136.
20. Thim L (1989). A new family of growth factor-like peptides. 'Trefoil' disulphide loop structures as a common feature in breast cancer associated peptide (pS2), pancreatic spasmolytic polypeptide (PSP), and frog skin peptides (spasmolysins). FEBS Lett 250:85-90.
21. Vollmers HP, Stulle K, Dämmrich J, Pfaff M, Papadopoulos Th, Betz C, Saal K, and Müller-Hermelink HK (1993). Characterization of four new gastric cancer cell lines. Virchows Arch B Cell Pathol 63:335-343.
22. Wong WM, Poulsom R, and Wright NA (1999). Trefoil peptides. Gut 44:890-895.
23. Wright NA, Poulsom R, Stamp G, Van Norden S, Sarraf C, Elia G, Ahnen D, Jeffery R, Longcroft J, Pike C, Rio MC, and Chambon P (1993). Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease. Gastroenterology 104:12-20.